Brief Article
Copyright ©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2010; 16(38): 4838-4845
Published online Oct 14, 2010. doi: 10.3748/wjg.v16.i38.4838
Figure 3
Figure 3 Changes in alanine transaminase. The alanine transaminase (ALT) level in the erythropoietin (EPO)1 group was significantly lower than that in the steroid (STRD) and EPO2 groups on Day 0 (P = 0.020, Kruskal-Wallis test) and Day 1 (P = 0.004, Kruskal-Wallis test). There were no significant differences in the ALT level after Day 3. Note that the scale of the Y-axis differs in each graph. SS: Statistically significant.